Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Brooklyn ImmunoTherapeutics, Inc. | Director | Stock Option | 67K | Dec 8, 2021 | Direct | ||
IN8BIO, INC. | Director | Stock Option (right to buy) | 33.7K | Jun 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
INAB | IN8BIO, INC. | Jun 12, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
INAB | IN8BIO, INC. | Jun 15, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
INAB | IN8BIO, INC. | Aug 16, 2022 | 1 | $999 | 4 | Aug 18, 2022 | Director |
INAB | IN8BIO, INC. | Jun 1, 2022 | 1 | $0 | 4/A | Sep 23, 2022 | Director |
ERNA | Brooklyn ImmunoTherapeutics, Inc. | Dec 8, 2021 | 1 | $0 | 4 | Dec 10, 2021 | Director |
INAB | IN8BIO, INC. | Jul 29, 2021 | 1 | $0 | 4 | Aug 2, 2021 | Director |
INAB | IN8BIO, INC. | Jul 29, 2021 | 0 | $0 | 3 | Jul 29, 2021 | Director |